| |
AIDS 2018 Conference Amsterdam 23 -27 July
This year CHIP will be represented at the AIDS 2018 conference with 1 oral presenation, 5 poster presentaions and take part in 4 symposia.
Find details of all presentations here
|
PARTNER presentation at IAS 2018!
At IAS 2018 the final results from the PARTNER study will be presented on 25th July 11:00 AM. The PARTNER study is the largest & longest study (since 2009) assesing risk of HIV transmission between serodifferent gay couples.
https://www.chip.dk/Studies/PARTNER
|
NEW PERSIMUNE publication
Rapid estimation of severity of new pandemic influenza types is essential to gauge appropriate level of intervention; the some severe the more intense the intervention. During the 2009 pandemic, Mexican authorities reported substantial severity expressed as a high case fatality rate. In this report, prof Lone Simonsen from CHIP/PERSIMUNE at Righospitalet uses data from a global cohort study lead by INSIGHT to estimate this rate, and find that it was 16 fold lower than initial estimates. These observations can be used to more reliable assess severity in next influenza pandemic. Find the full publication here
|
Vacant position at CHIP for Public Health Student
CHIP is looking for a public health student to join the team.
Please find full job description and online application site here
Deadline for application is 25 April.
|
Next Immunologic Colloquim 18 April 2018
The next Immunologic Colloquium will take place 18 April 2018 15.30-16.30 at Rigshospitalet Department of Infectious Diseases.
Agenda
|
2 day course on Introduction to Cost-effectiveness Analysis for Infectious Diseases
25th - 26th September 2018 at UCL Royal Free Campus, London
The course is for people working in health care settings, academic environments, industry and governmental and non-governmental organisations who wish to achieve a basic understanding of, and be able to interpret, cost effectiveness analyses in the context of infectious diseases, with particular focus on HIV
Read more about the course and sign up here
|
CHIP and INSIGHT mourn the loss of Professors David Cooper and Fred Gordin who passed away 18 March
It is with incredible sadness that we have learned of the passing of two pillars of the INSIGHT network, Fred Gordin in Washington DC and David Cooper in Sydney.
Fred’s leadership in INSIGHT was unparalleled. He directed the Washington International Coordinating Centre, chaired CPCRA, the SMART and currently the START protocol. Fred’s scientific interests focused on pulmonary disease, and his life-long leadership in tuberculosis research is widely acknowledged.
David led the Sydney International Coordinating Centre of INSIGHT. David was a central figure in global HIV research for more than three decades and in forming INSIGHT’s studies and research output over the years. The Kirby Institute @ UNSW embodies David’s leadership. As former president of IAS and builder of research structures in Bangkok and elsewhere in Asia, David was an inspiring and visionary leader.
Fred and David will be sorely missed. Our thoughts are with their friends and families.
CHIP and INSIGHT honor their legacy.
|
New WHO surveillance protocol for viral hepatitis
The World Health Organization calls for better monitoring of viral hepatitis with the launch of a new protocol. The objective of the protocol is to improve the understanding of the link between viral hepatitis and the 2 main consequences: cirrhosis and hepatocellular carcinoma. Better understanding of linkages between viral hepatitis and liver cancer will be key to improving global and national policies and strategies to reduce deaths caused by both diseases.
The late presentation definition used in the protocol builds on a consensus definition developed in 2017 involving authors from CHIP
Read the full publication here:
Late presentation of chronic viral hepatitis for medical care: a consensus definition. Mauss et al.
Find the new WHO protocol for surveillance of viral hepatitis here
|
Next Immunologic Colloquim 21 March
The next Immunologic Colloqium will take place 21 March 15:30-16:00 @ Rigshospitalet Department of Infectious Diseases.
Agenda
|
HIV training and mentoring programme
CHIP has launched the HIV training and mentoring programme for Ukrainian doctors in collaboration with WHO Regional Office in Ukraine. During this week the Ukrainian doctors will visit different hospitals in Copenhagen Region and other health institutions to meet the infectious diseases specialists who will share their knowledge and present on international standards for HIV treatment and care.
|
HIV MEDICINE special issue: Outcomes of the HepHIV 2017 Malta Conference
In February 2018 HIV Medicine launched a special issue on the Outcomes of the HepHIV 2017 Malta Conference. The special issue provides an overview of the results of the HepHIV Conference 2017 organised by HIV in Europe.
Special Issue
|
CROI 2018
Conference on Retroviruses and Oppertunistic Infections 4 -7 March 2018.
CHIP will be represented at CROI 2018 with 2 presentations.
Please find all presentations here
|
Can hypothermia reduce organ dysfunction and mortality in patients with septic shock?
|
New publication: Results from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study
Marco Gelpi and collegues from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study affiliated with PERSIMUNE recently reported data indicating that even well-treated and in particular older HIV-positive persons remains having a distrinct pro-atherogenic phenotype compared to age and gender matched sections of the general population. This observation renders supports for notions from other sections of research by CHIP and PERSIMUNE, that HIV status is an independent risk factor for cardiovascular disease. Research focused on identifying mechanisms explaining the development of the phenotype and interventions to contract its likely adverse reactions is underway.
Abstract
|
Vacant position as Research Associate/Statistician
The Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), within the Institute for Global Health, are seeking to appoint a Medical Statistician/Research Associate with a passion and interest in applying statistical methods to clinically relevant questions and helping with interpretation of complex statistical analyses. The Group contains a large number of statisticians and epidemiologists working on the design and analysis of studies in HIV infection and other infectious diseases.
Please find job description and apply here
Deadline for application: 12 March 2018
|
|